FDA approves tiny Medtronic lead for LBBA placement | A new business model | CV risks & cognitive function | Telehealth trends

The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.

The new approach allows private practices to expand and evolve without being acquired.

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial. 

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

The years-long scheme involved sending kickbacks to physicians who ordered unnecessary transcranial doppler exams. Two conspirators have now been sentenced to prison and ordered to pay substantial fines.

Newer imaging technologies designed to use less radiation have made a considerable impact. In parts of the world where those systems have not yet been implemented, however, radiation dose levels remain quite high. 

Patients electing to undergo a whole-body MRI at one Florida facility are now able to undergo a CCTA exam at the same time. All results are interpreted by a cardiologist, and the patient meets with a physician for a one-on-one consultation.  

The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.  

Federal policy is bandaging localized nursing shortages while ignoring the patient’s serious internal illness.